176 related articles for article (PubMed ID: 26334751)
1. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
[TBL] [Abstract][Full Text] [Related]
2. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.
Navarro-Martin A; Aso S; Cacicedo J; Arnaiz M; Navarro V; Rosales S; de Blas R; Ramos R; Guedea F
J Thorac Oncol; 2016 Jul; 11(7):1101-11. PubMed ID: 27103512
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Machuzak M; Mazzone P; Videtic GM
J Thorac Oncol; 2009 Jul; 4(7):838-44. PubMed ID: 19487961
[TBL] [Abstract][Full Text] [Related]
4. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
[TBL] [Abstract][Full Text] [Related]
5. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
6. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
[TBL] [Abstract][Full Text] [Related]
7. Changes in Pulmonary Function After Stereotactic Body Radiotherapy and After Surgery for Stage I and II Non-small Cell Lung Cancer, a Description of Two Cohorts.
Alberts L; El Sharouni SY; Hofman FN; Van Putte BP; Tromp E; Van Vulpen M; Kastelijn EA; Schramel FM
Anticancer Res; 2015 Dec; 35(12):6773-9. PubMed ID: 26637895
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
[TBL] [Abstract][Full Text] [Related]
10. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
Henderson M; McGarry R; Yiannoutsos C; Fakiris A; Hoopes D; Williams M; Timmerman R
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):404-9. PubMed ID: 18394819
[TBL] [Abstract][Full Text] [Related]
11. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?
Guckenberger M; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Grills IS
J Thorac Oncol; 2012 Mar; 7(3):542-51. PubMed ID: 22258475
[TBL] [Abstract][Full Text] [Related]
12. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
Margaritora S; Cesario A; Cusumano G; Cafarotti S; Corbo GM; Ferri L; Ceppi M; Meacci E; Valente S; D'Angelillo RM; Russo P; Porziella V; Bonassi S; Pasqua F; Sterzi S; Granone P
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1457-63. PubMed ID: 20363001
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
[TBL] [Abstract][Full Text] [Related]
17. Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors.
Ohashi T; Takeda A; Shigematsu N; Kunieda E; Ishizaka A; Fukada J; Deloar HM; Kawaguchi O; Takeda T; Takemasa K; Isobe K; Kubo A
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1003-8. PubMed ID: 15990001
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function testing after stereotactic body radiotherapy to the lung.
Bishawi M; Kim B; Moore WH; Bilfinger TV
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e107-10. PubMed ID: 21470798
[TBL] [Abstract][Full Text] [Related]
19. Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer.
Videtic GMM; Woody NM; Reddy CA; Stephans KL
Pract Radiat Oncol; 2017; 7(6):e543-e549. PubMed ID: 28867545
[TBL] [Abstract][Full Text] [Related]
20. Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective study.
Enache I; Noel G; Jeung MY; Meyer N; Oswald-Mammosser M; Pistea C; Jung GM; Mennecier B; Quoix E; Charloux A
Respiration; 2013; 86(2):100-8. PubMed ID: 23154264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
